Atlas Trials

Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.

Clinical trial NCT03244709 · UNKNOWN

Trial details

NCT number
NCT03244709
Sponsor
Hospital of Prato
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Giant Cell Arteritis
Start date
2015-01-01
Primary completion
2017-12-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.